Presentations

Presentations [IO Summit 2022] Implementing MOA-Reflective ADCC & ADCP Cytotoxicity Assays Using Ready-to-Use KILR® Target & Effector Cells from Screening to Lot Release

Jane E. Lamerdin, Ph.D. Vice President, Research & Development Eurofins DiscoverX

Presentations [Immuno-Oncology Summit 2021] Accelerating Immunotherapy Drug Development with Simple Cell-Based Assays for Immune Checkpoint Receptors

Jennifer Lin-Jones, Ph.D. Senior Group Leader, Assay Development

Presentations [Festival of Biologics EU 2021] Accelerating Immunotherapy Drug Development Targeting Checkpoints with Robust MOA-Based Assays

Presented by Dr. Alexander Baumann Head of European Business Development Eurofins DiscoverXProducts

Presentations [BEBPA NA 2020] Qualification of Ready-to-Use Cell-Based Assays for Potency to Support Immunology and Immunotherapy Drug Development

Presenter: Jane Lamerdin, Ph.D., Director of R&D, Eurofins DiscoverX

Presentations [DOT 2022] Targeted Protein Degrader Discovery Using the SPRINTer™ Cell-Based Assay Platform

Chao-Tsung Yang, Ph.D., Principal Scientist Group Leader R&D Department Eurofins DiscoverX, Fremont, CA

Presentations [DOT 2021] Targeted Protein Degrader Discovery Using the E3scan™ Technology Platform and SPRINTer™ Cell Lines

Ksenya Cohen Katsenelson, Ph.D. Group Leader, R&D, Eurofins Discovery, San Diego, CA Chao-Tsung Yang, Ph.D. Group Leader, R&D, Eurofins DiscoverX,…

Presentations [DOT 2021] Functional, Automatable & MOA-Reflective Cell-Based Bioassays for Accelerating Drug Discovery & QC Lot Release Programs

Gaurav Agrawal, Ph.D. Scientific Development Manager, Eurofins DiscoverX

Presentations [DOT 2020] E3scan™ Ligand Binding Assay Platform and SPRINTer™ Cell Lines for Targeted Protein Degradation and PROTAC® Discovery

Ksenya Cohen Katsenelson, Ph.D. Group Leader, R&D, San Diego Chao-Tsung Yang, Ph.D. Principal Scientist, R&D, Fremont

Presentations [DOT 2020] Accelerate Your COVID-19 Drug Discovery with Qualified Cell-Based Assays for Proinflammatory Cytokines

Gaurav Agrawal, Ph.D. Scientific Development Manager, Eurofins DiscoverX

Presentations [Cytokines Summit 2022] Enabling Cytokine Therapeutic Development with Qualified, Functional Cell-Based Assays

Gaurav Agrawal, Ph.D.Scientific Development Manager Discover how cell-based assays and translational services accelerate cytokine-based immunotherapeutic development from early discovery to…

Presentations [CD47/SIRPa Summit 2020] A Novel MOA-reflective Bioassay for Quantifying Potency of Therapeutics Targeting the SIRPα|CD47 Signaling Axis

Watch Recorded Presentation Jane Lamerdin, Ph.D. Director R&D, Eurofins DiscoverX

Presentations [CASSS 2017] Robust and Reproducible ADCC and T Cell Redirection with CD16-Engineered Effector Cells

DiscoverX CASSS 2017 Presentation Presented by Dr. Jane Lamerdin, Director R&D, DiscoverX May 9, 2017